{"schema_version":"secwatch.filing_event.v1","accession":"0000937556-25-000003","form_type":"8-K","ticker":"MASI","cik":"0000937556","company_name":"MASIMO CORP","filed_at":"2025-01-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.879549+00:00","generated_at":"2026-05-28T00:45:49.538901+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Masimo reports preliminary Q4 2024 revenue ~$601M, healthcare up 9%; issues FY 2025 guidance","bullets":["Q4 2024 consolidated revenue ~$601M (+9% YoY); healthcare revenue ~$368M (+8% reported, +9% constant currency).","FY 2024 consolidated revenue ~$2,094M (+2%); healthcare $1,395M (+9%); non-healthcare $699M (-10%).","Non-GAAP EPS FY 2024 expected >$4.10 (high end of prior guidance range).","FY 2025 healthcare revenue guidance $1,500M-$1,530M (8-11% constant currency growth); non-GAAP EPS $4.90-$5.10.","Q4 shipments of noninvasive technology boards/instruments ~65K units."],"urls":{"canonical":"https://secwatch.observer/filing/0000937556-25-000003","json":"https://secwatch.observer/filing/0000937556-25-000003.json","markdown":"https://secwatch.observer/filing/0000937556-25-000003.md","text":"https://secwatch.observer/filing/0000937556-25-000003.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/937556/000093755625000003/0000937556-25-000003-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/937556/000093755625000003/masi-20250116.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T00:45:49.538901+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}